propofol has been researched along with concanavalin a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Perttilä, J; Pirttikangas, CO; Salo, M | 1 |
1 trial(s) available for propofol and concanavalin a
Article | Year |
---|---|
Propofol emulsion reduces proliferative responses of lymphocytes from intensive care patients.
Topics: Adolescent; Adult; Aged; B-Lymphocytes; Chemistry, Pharmaceutical; Concanavalin A; Critical Illness; Dose-Response Relationship, Drug; Fat Emulsions, Intravenous; Humans; Immunocompromised Host; Intensive Care Units; Lymphocyte Activation; Lymphocytes; Middle Aged; Phytohemagglutinins; Pokeweed Mitogens; Propofol; Severity of Illness Index; Trauma Severity Indices | 1993 |